Navigation Links
New Research Shows Antidepressants May Thwart Breast Cancer Treatment
Date:5/30/2009

Popular antidepressants taken with tamoxifen can increase the risk of breast cancer recurrence

PHILADELPHIA, May 30 /PRNewswire-USNewswire/ -- A new study found that taking tamoxifen with certain antidepressants more than doubled the risk of breast cancer recurrence in women taking both medications. The antidepressants inhibit an enzyme, CYP2D6, which helps tamoxifen work effectively.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090530/DC24767LOGO)

The study was conducted by researchers from Medco and the Indiana University School of Medicine and presented Saturday at the American Society of Clinical Oncology (ASCO) meeting in Orlando.

Approximately 500,000 U.S. women take tamoxifen, a medicine that blocks the effects of estrogen in breast tissue. Estrogen can make certain types of breast cancer (hormone-receptor-positive breast cancers) grow. About 30 percent of women taking tamoxifen also are taking an antidepressant to treat depression and/or to ease hot flashes, a common side effect of tamoxifen. "With more than 100,000 women potentially affected, these data represent a significant health finding," asserts Dr. Marisa Weiss, president and founder of Breastcancer.org and a breast oncologist at Lankenau Hospital in the Philadelphia area.

Preliminary, limited information from another study conducted by researchers from the Netherlands appears to offer conflicting results. The Dutch study suggests taking tamoxifen with specific antidepressants doesn't affect breast cancer recurrence rates.

"We don't want to dismiss the findings of the Dutch study; however, from what we've learned, there were fewer women in the Dutch study taking antidepressants in combination with tamoxifen, and it appears that they were taken together for a shorter period of time," says Dr. Weiss. "Regardless, there is considerable evidence in the Medco/Indiana University study, as well as in other smaller studies conducted during the past few years, to give physicians and patients reason to question using certain antidepressants (and other types of medications that might block the CYP2D6 enzyme) together with tamoxifen."

Tamoxifen has been used to successfully treat millions of women diagnosed with hormone-receptor-positive breast cancer. It can reduce the risk of cancer recurrence by about 50 percent.

"With the life-saving advantages of tamoxifen, it's imperative that women taking it derive the greatest benefit they can," says Dr. Weiss. "Women make a daily commitment to tamoxifen and deserve to get the maximum benefit this medicine affords."

She pointed out that there are safe and effective alternatives to manage depression and hot flashes that doctors can offer patients taking tamoxifen. Weiss advises women who have taken tamoxifen along with an antidepressant in the past and those who currently are taking these medicines together to talk to their doctors. Anyone with questions also can find information at Breastcancer.org.

"Since tamoxifen is the cornerstone of care for hundreds of thousands of women across the globe, this study will likely raise a lot of questions about whether to continue to use tamoxifen or change treatments, as well as whether women who stopped taking tamoxifen should restart. These new data represent an important insight into maximizing the effectiveness of breast cancer treatment," says Dr. Weiss.

About Breastcancer.org Breastcancer.org, a nonprofit organization, is the #1 online resource for medically reviewed information on breast health and breast cancer - with over 6,000 pages of medically vetted information and reaching 8 million people worldwide each year.


'/>"/>
SOURCE Breastcancer.org
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Mayo Researchers Help Discover Genetic Cause for Primary Biliary Cirrhosis
2. Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
3. New Phase 3 Study of Tapentadol Immediate Release Tablets Published in Current Medical Research and Opinion Journal
4. Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures
5. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
6. U.S. Naval Medical Research Center Proposed RESUS Clinical Trial in Trauma Patients Remains on FDA Hold
7. Juvenile Diabetes Research Foundation to Honor Duane DeSisto of Insulet Corporation and Senator Edward M. Kennedy at 27th Annual Hearts & Heroes Gala
8. New Research Shows Nutrition 21s Chromium Histidinate Improves Markers for Mood and Carbohydrate Cravings
9. Hooters of Orange Park to Host Charity Car Wash Raising Money for Breast Cancer Research
10. Autism Studies Presented at Mid-Atlantic Research Consortium Meeting
11. ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , December 7, 2016 ... Market Research titled , Global Market Study on Multiplex Detection ... 2024 , the global multiplex detection immunoassay market is expected ... period 2016-2024. ... , , ...
(Date:12/7/2016)... , December 7, 2016 ... reach a value of USD 3.9 billion by ... View Research, Inc. The growth of the market ... and continuous technological advancements by the market players. ... due to increasing donation, rising awareness about transfusion-transmitted ...
(Date:12/6/2016)... , Dec. 6, 2016  Alopexx Oncology, LLC ... a recombinant antibody fusion protein (immunocytokine) composed of interleukin-2 ... the same target on B cells as Rituxan and ... components but is also involved in tumor targeting, engagement ... vaccine effect. The results of the study (abstract #95954) ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... 07, 2016 , ... The Honolulu cosmetic and medical dermatology ... launched October 17, 2016, features comprehensive information regarding a wide range of dermatologic ... patients can discover the latest clinical dermatology treatments for medical skin concerns as ...
(Date:12/7/2016)... TX (PRWEB) , ... December 07, 2016 , ... ... based in Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith ... bring these scam operations to a halt. According to Texas Premier Locksmith, these ...
(Date:12/7/2016)... ... December 07, 2016 , ... "ProBrand Flip allows FCPX ... media," said Christina Austin - CEO of Pixel Film Studios. , ProBrand Flip includes ... use drop zones. Editors can select from a variety of flip book animations. In ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... (IFW) Program at Reproductive Medicine Associates of Connecticut (RMACT). McLaughlin brings nearly 20 ... of three acupuncturists to help patients realize their family building goals. Acupuncture ...
(Date:12/7/2016)... , ... December 07, 2016 , ... “Walking With God: ... stories that will inspire the reader to be aware of God's direction in their ... published author, Sanford Smith, retired teacher and active church leader. , Sanford ...
Breaking Medicine News(10 mins):